Dougherty & Co Reiterates a 'Buy' on Sequenom (SQNM); Confidence in Roll-Out of MaterniT21 Test
Tweet Send to a Friend
Dougherty & Co reiterates a 'Buy' on Sequenom (NASDAQ: SQNM) price target of $6.50.
Analyst, Junaid Husain, said, "Sequenom ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Analyst, Junaid Husain, said, "Sequenom ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE